REQUEST A DEMO
Total
USD $0.00
Search more companies

Neumologos de Santander S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Neumologos de Santander S.A.S. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Neumologos de Santander S.A.S. is based in Colombia. The head office is in Floridablanca. The enterprise operates in the Ambulatory Health Care Services industry. It was incorporated on November 12, 1993. 47 (2024) employees currently work for Neumologos de Santander S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 21.64% in 2023. Its total assets grew by 2.36% over the same period. In, 2023, the company’s net profit margin increased by 3.9%.

Headquarters
Cr. 24 # 154-106 Cons. 311
Floridablanca; Santander;

Contact Details: Purchase the Neumologos de Santander S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Neumologos de Santander S.A.S. report to view the information.
Outstanding Shares:
Purchase the Neumologos de Santander S.A.S. report to view the information.
Incorporation Date:
November 12, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Neumologos de Santander S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
21.64%
Total operating revenue
21.64%
Operating profit (EBIT)
456.63%
EBITDA
306.3%
Net Profit (Loss) for the Period
1244.01%
Total assets
2.36%
Total equity
-1.58%
Operating Profit Margin (ROS)
6.37%
Net Profit Margin
3.9%
Return on Equity (ROE)
7.02%
Debt to Equity Ratio
-0.05%
Quick Ratio
-1.07%
Cash Ratio
-0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?